Trans-Resveratrol Induces Apoptosis through ROS-Triggered Mitochondria-Dependent Pathways in A549 Human Lung Adenocarcinoma Epithelial Cells

Planta Medica

Volumn 81, Issue 12-13, 2015, Pages 1038-1044

  Lucas, Ina Katharina ^a   Kolodziej, Herbert ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

A549 cells; apoptosis; caspases; cytotoxicity; resveratrol; ROS

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; CASPASE 3; CASPASE 8; CASPASE 9; REACTIVE OXYGEN METABOLITE; RESVERATROL; STAUROSPORINE; TRANS RESVERATROL; UNCLASSIFIED DRUG; CASP8 PROTEIN, HUMAN; DIACETYLDICHLOROFLUORESCEIN; FLUORESCEIN DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; STILBENE DERIVATIVE; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE;

A549 CELL LINE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL DEATH; CELL FUNCTION; CELL MEMBRANE; CELL POPULATION; CELL VIABILITY; CIS ISOMER; COLORIMETRY; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG CYTOTOXICITY; ENZYME ACTIVITY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; INCUBATION TIME; MITOCHONDRION; OXIDATIVE STRESS; RESPIRATORY CHAIN; TRANS ISOMER; WESTERN BLOTTING; ADENOCARCINOMA; CELL SURVIVAL; DRUG EFFECTS; EPITHELIUM CELL; LUNG NEOPLASMS; METABOLISM; TUMOR CELL LINE;

ADENOCARCINOMA; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; CASPASE 3; CASPASE 8; CELL LINE, TUMOR; CELL SURVIVAL; EPITHELIAL CELLS; FLUORESCEINS; HUMANS; LUNG NEOPLASMS; MITOCHONDRIA; REACTIVE OXYGEN SPECIES; STILBENES; TETRAZOLIUM SALTS; THIAZOLES;

EID: 84939650671     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0035-1546129     Document Type: Article

References (44)

1. Baur J. A., Sinclair D. A. Therapeutic potential of resveratrol: the in vivo evidence. Nature Rev: 2006; 5 493 506
2. Athar M., Back J. H., Tang X., Kim K. H., Kopelovich L., Bickers D. R., Kim A. L. Resveratrol: a review of preclkinical studies for human cancer prevention. Toxicol Appl Pharmacol: 2007; 224 274 283
3. Vang O., Ahmad N., Baile C. A., Baur J. A., Brown K. What is new for an old molecule? Systematic review and recommendations on the use of resveratrol. PLoS One: 2011; 6 1 11
4. Aggarwal B. B., Bhardwaj A., Aggarwal R. S., Seeram N. P., Shishodia S., Takada Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res: 2004; 24 2783 2840
5. Lancon A., Kaminski J., Tili E., Michaille J. J., Latruffe N. Control of microRNA expression as a new way for resveratrol to deliver its beneficial effects. J Agric Food Chem: 2012; 60 8783 8789
6. Brown V. A., Patel K. R., Viskaduraki M., Crowell J. A., Perloff M., Booth T. D., Vasilinin G., Sen A., Schinas A. M., Piccirilli G., Brown K., Steward W. P., Gescher A. J., Brenner D. E. Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis. Cancer Res: 2010; 70 9003 9011
7. Patel K. R., Brown V. A., Jones D. J., Britton R. G., Hemingway D., Miller A. S., West K. P., Booth T. D., Perloff M., Crowell J. A., Brenner D. E., Steward W. P., Gescher A. J., Brown K. Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res: 2010; 70 7392 7399
8. Howells L. M., Berry D. P., Elliott P. J., Jacobsen E. W., Hoffmann E., Hegarty B., Brown K., Steward W. P., Gescher A. J. Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases-safety, pharmacokinetics, and pharmacodynamics. Cancer Prev Res (Phila): 2011; 4 1419 1425
9. Patel K. R., Scott E., Brown V. A., Gescher A. J., Steward W. P., Brown K. Clinical trials of resveratrol. Ann N Y Acad Sci: 2011; 1215 161 169
10. Whyte L., Huang Y., Torres K., Mehta R. G. Molecular mechanisms of resveratrol action in lung cancer cells using dual protein and microarray analyses. Cancer Res: 2007; 67 12007 12017
11. Zhang W., Wang X., Chen T. Resveratrol induces apoptosis via a Bak-mediated intrinsic pathway in human lung adenocarcinoma cells. Cell Signal: 2012; 24 1037 1046
12. Luo H., Yang A., Schulte B. A., Wargovich M. J., Wang G. Y. Resveratrol induces premature senescence in lung cancer cells via ROS-mediated DNA damage. PLoS One: 2013; 8 e60065
13. Zhang J., Ma K., Qi T., Wei X., Zhang Q., Li G., Chiu J. P62 regulates resveratrol-mediated Fas/Cav-1 complex formation and transition from autophagy to apoptosis. Oncotarget: 2015; 6 789 801
14. Yuan L., Zhang Y., Xia J., Liu B., Zhang Q., Liu J., Luo L., Peng Z., Song Z., Zhu R. Resveratrol inducers cell cycle arrest via a p 53-independent pathway in A549 cells. Mol Med Rep: 2015; 11 2459 2464
15. Gu S., Chen C., Jiang X., Zhang Z. Resveratrol synergistically triggers apoptotic cell death with arsenic trioxide via oxidative stress in human lung adenocarcinoma A549 cells. Biol Trace Elem Res: 2015; 163 112 123
16. Juan M. E., Wenzel U., Daniel H., Planas J. M. Resveratrol induces apoptosis through ROS-dependent mitochondria pathway in HT-29 human colorectal carcinoma cell. J Agric Food Chem: 2008; 56 4813 4818
17. Shao J., Li X., Lu X., Jiang C., Hu Y., Li Q., You Y., Fu Z. Enhanced growth inhibition effect of resveratrol incorporated into biodegradable nanoparticles against glioma cells is mediated by the induction of intracellular reactive oxygen species levels. Colloids Surf B Biointerfaces: 2009; 72 40 47
18. Miki H., Uehara N., Kimura A., Sasaki T., Yuri T., Yoshizawa K., Tsubura A. Resveratrol induces apoptosis via ROS-triggered autophagy in human colon cancer cells. Int J Oncol: 2012; 40 1020 1028
19. Trela B., Waterhouse A. Resveratrol: isomeric molar absorptivities and stability. J Agric Food Chem: 1996; 44 1253 1257
20. Montsko G., Nikfardjam M. SP, Szabo Z., Boddi K., Lorand T., Ohmacht R., Mark L. Determination of products derived from trans-resveratrol UV photoisomerisation by means of HPLC-APCI-MS. J Photochem Photobiol A: 2008; 196 44 50
21. Yu C., Shin Y. G., Chow A., Li Y., Kosmeder J. W., Lee Y. S., Hirschelman W. H., Pezzuto J. M., Mehta R. G., van Breemen R. B. Human, rat, and mouse metabolism of resveratrol. Pharm Res: 2002; 19 1907 1914
22. Liu B., Xu K., Han H., Wang T., Song Y. Effect of resveratrol on apoptosis of lung adenocarcinoma cell line A549. Zhonghua Zhongliu Fangzhi Zazhi: 2014; 21 740 743
23. Liu P. L., Tsai J. R., Charles A. L., Hwang J. J., Cou S. H., Ping Y. H., Lin F. Y., Chen Y. L., Hung C. Y., Chen W. C., Chen Y. H., Chong I. W. Resveratrol inhibits human lung adenocarcinoma cell metastasis by suppressing heme oxygenase 1-mediated nuclear factor- κ B pathway and subsequently downregulating expression of matrix metalloproteinases. Mol Nutr Food Res: 2010; 54 02 S196 S204
24. Chen J., Lv J., Shu Y. Effects of resveratrol on cell cycle regulatory processes of human lung adenocarcinoma A549 cells and its mechanism. Linchuang Zhongliuxue Zazhi: 2011; 16 506 509
25. Yin H. T., Tian Q. Z., Guan L., Zhou Y., Huang X. E., Zhang H. In vitro and in vivo evaluation of the antitumor efficiency of resveratrol against lung cancer. Asian Pac J Cancer Prev: 2013; 14 1703 1706
26. Huang C., Ma W., Goranson A., Dong Z. Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. Carcinogenesis: 1999; 20 237 242
27. Lucas I. K., Kolodziej H. In vitro antileishmanial activity of resveratrol originates from its cytotoxic potential against host cells. Planta Med: 2013; 79 20 26
28. Low I. CC, Chen Z. Y., Pervaiz S. Bcl-2 modulates resveratrol-induced ROS production by regulating mitochondrial respiration in tumor cells. Antioxid Redox Signal: 2010; 13 807 819
29. Gokbulut A. A., Apohan E., Baran Y. Resveratrol and quercetin-induced apoptosis of human 232B4 chronic lymphocytic leukemia cells by activation of caspase-3 and cell cycle arrest. Hematology: 2013; 18 144 150
30. Ewald J. A., Desotelle J. A., Wilding G., Jaarrard D. F. Therapy-induced senescence in cancer. J Natl Cancer Inst: 2010; 102 1536 1546
31. Shankar S., Siddiqui I. Molecular mechanisms of resveratrol (3,4,5-trihydroxy-trans-stilbene) and its interaction with TNF-related apoptosis inducing ligand (TRAIL) in androgen-insensitive prostate cancer cells. Mol Cell Biochem: 2007; 304 273 285
32. Hussain A. R., Uddin S., Bu R., Khan O. S., Ahmed S. O., Ahmed M., Al-Kuraya K. S. Resveratrol suppresses constitutive activation of AKT via generation of ROS and induces apoptosis in diffuse large B cell lymphoma cell lines. PLoS One: 2011; 6 e24703
33. Salganik R. I. The benefits and hazards of antioxidants: controlling apoptosis and other protective mechanisms in cancer patients and the human population. J Am Coll Nutr: 2001; 20 05 464S 472S
34. Seifried H. E., Anderson D. E., Fisher E. I., Milner J. A. A review of the interaction among dietary antioxidants and reactive oxygen species. J Nutr Biochem: 2007; 18 567 579
35. Schieber M., Chandel N. S. ROS function in redox signaling and oxidative stress. Curr Biol: 2014; 24 R453 R462
36. Ye Z., Zhang J., Townsend D. M., Tew K. D. Oxidative stress, redox regulation and diseases of cellular differentiation. Biochim Biophys Acta: 2015; 1850 1607 1621
37. De Roos B., Duthie G. G. Role of dietary pro-oxidants in the maintenance of health and resilience to oxidative stress. Mol Nutr Food Res 10.1002/mnfr.201400568 advance online publication 22 January 2015
38. Colin D. J., Limagne E., Ragot K., Lizard G., Ghiringhelli F., Solary E., Chauffert B., Latruffe N., Delmas D. The role of reactive oxygen species and subsequent DNA-damage response in the emergence of resistance towards resveratrol in colon cancer models. Cell Death Dis: 2014; 5 e1533
39. Hadi S. M., Ullah M. F., Shamim U., Hanf S. S., Azmi A. S., Bhat S. H. A prooxidant mechanism of red wine polyphenols in chemoprevention of cancers. In: O'Byrne P. editor Red wine and health. New York Nova Science Publishers Inc.: 2009; 373 388
40. Azmi A. S., Hadi S., Mohammad R. M. Prooxidant anti-cancer mechanisms of resveratrol: An evolving yet underappreciated phenomenon. 3rd International Conference of Resveratrol and Health, Waikoloa, HI. 2014
41. Mukherjee S., Dudley J. I., Das D. K. Dose-dependency of resveratrol in providing health benefits. Dose Response: 2010; 8 478 500
42. Singh C. K., Ndiaye M. A., Ahmad N. Resveratrol and cancer: Challenges for clinical translation. Biochim Biophys Acta: 2015; 1852 1178 1185
43. Scott E., Steard W. P., Gescher A. J., Brown K. Resveratrol in human cancer chemoprecention - choosing the 'right' dose. Mol Nutr Food Res: 2012; 56 7 13
44. Mosman T. J. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J Immunol Methods: 1983; 65 55 63